Black Rock Inc. Avidity Biosciences, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,165,991 shares of RNA stock, worth $166 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,165,991

Previous 6,496,593 5.09%

Holding current value

$166 Million

Previous $58.8 Million 167.64%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.16 - $25.52 $3.03 Million - $8.44 Million	-330,602 Reduced 5.09%	6,165,991 $157 Million
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $3.46 Million - $6.65 Million	710,018 Added 12.27%	6,496,593 $58.8 Million
Q3 2023 Nov 13, 2023	BUY	$6.3 - $11.35 $175,322 - $315,859	27,829 Added 0.48%	5,786,575 $36.9 Million
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $1.33 Million - $2.17 Million	125,321 Added 2.22%	5,758,746 $63.9 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $5.33 Million - $8.91 Million	347,251 Added 6.57%	5,633,425 $86.5 Million

Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $11.7 Million - $26.4 Million	1,164,537 Added 28.25%	5,286,174 $117 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $2.94 Million - $4.45 Million	189,975 Added 4.83%	4,121,637 $67.3 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $7.44 Million - $13.6 Million	665,653 Added 20.38%	3,931,662 $57.1 Million
Q1 2022 May 12, 2022	SELL	$14.2 - $23.78 $446,888 - $748,380	-31,471 Reduced 0.95%	3,266,009 $60.3 Million
Q4 2021 Feb 10, 2022	BUY	$20.4 - $28.66 $1.73 Million - $2.43 Million	84,704 Added 2.64%	3,297,480 $78.4 Million
Q3 2021 Nov 09, 2021	BUY	$18.16 - $25.21 $9.31 Million - $12.9 Million	512,411 Added 18.98%	3,212,776 $79.1 Million
Q2 2021 Aug 11, 2021	BUY	$19.62 - $29.26 $53 Million - $79 Million	2,700,365 New	2,700,365 $66.7 Million

Others Institutions Holding RNA

# of Institutions

164

Shares Held

71.6M

Call Options Held

182K

Put Options Held

55K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.4B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account